Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

Summary

This study is being conducted to evaluate the efficacy and safety of ASA compared to placebo in the management of osteoarthritis (OA) symptoms of the knee.

Timeline

Start

2020-12-14

Primary completion

2023-07-30

Completion

2025-08-19

Outcome

Met primary endpoint

release “ReNu, a cryopreserved amniotic suspension allograft (ASA), for the management of symptoms associated with knee osteoarthritis (OA) achieved its primary endpoint” organogenesis.com ↗

Drugs

Indications